Linked Data API
Show Search Form
Search Results
 |
human indexable |  |
 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
published | |
|
||||||||
|
registered interest |  |
|
||||||||
|
answer date |   |
|||||||||
|
date | |
|||||||||
|
date tabled | |
|||||||||
|
ddp created | |
|||||||||
|
answering body |
|
|||||||||
|
question status | Tabled | |
||||||||
|
answering dept id | 17 | |
||||||||
|
answering dept short name | Health and Social Care | |
||||||||
|
answering dept sort name | Health and Social Care | |
||||||||
|
ddp modified |
|
|||||||||
|
hansard heading | Trastuzumab Deruxtecan | |
||||||||
|
house id | 1 | |
||||||||
|
identifier | 20865 | |
||||||||
|
legislature |
|
|||||||||
|
parliament number | 58 | |
||||||||
|
question first answered |
|
|||||||||
|
question text | To ask the Secretary of State for Health and Social Care, whether NICE is taking steps to make Enhertu available to the National Health Service to treat incurable HER2-low secondary breast cancer. | |
||||||||
|
session |
|
|||||||||
|
session number | 4 | |
||||||||
|
tabling member constituency | South Holland and The Deepings | |
||||||||
|
tabling member printed |
|
|||||||||
|
title | House of Commons Tabled Parliamentary Question 2023/24 20865 | |
||||||||
 |
type |
|
|||||||||
|
uin | 20865 | |
||||||||
|
version | 1 | |
||||||||
|
written parliamentary question type | Ordinary | |
||||||||
|
answer | answer | |||||||||
|
creator |
|
|||||||||
|
publisher | 25259 | |||||||||
|
tabling member |
|
|||||||||
